Future research will determine the extent to which the CXCL12-dependent regulation of PKM2 through CXCR4 or ACKR3, either alone or in combination, controls the metabolic states of cancer cells relative to other downstream effectors, with established effects on the metabolism. This evidence concerns the gene CXCR4 and cancer.